BIOMAT Database Logo BIOMAT Database Logo

Treatment of rapidly progressive IgA nephropathy. 1995

D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Istituto di Nefrourologia, Università di Torino, Italia.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D005922 Glomerulonephritis, IGA A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE. Berger Disease,Immunoglobulin A Nephropathy,Nephropathy, IGA,Berger's Disease,IGA Glomerulonephritis,IGA Nephropathy,Iga Nephropathy 1,Nephritis, IGA Type,Bergers Disease,Glomerulonephritides, IGA,IGA Type Nephritis,Nephropathy 1, Iga,Nephropathy, Immunoglobulin A

Related Publications

D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Rapidly progressive IgA nephropathy.
March 2005, Indian journal of pediatrics,
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Rapidly progressive IgA nephropathy.
March 2005, Indian journal of pediatrics,
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Rapidly progressive IgA nephropathy.
July 1988, American journal of diseases of children (1960),
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Treatment of progressive IgA nephropathy.
January 2002, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
IgA nephropathy with rapidly progressive course after kidney transplantation.
January 1991, Nephron,
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy.
January 2023, Frontiers in pharmacology,
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Post-reperfusion rapidly progressive glomerulonephritis in post-transplant IgA nephropathy.
January 2004, Journal of nephrology,
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy.
June 2007, Pediatric nephrology (Berlin, Germany),
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Treatment of IgA Nephropathy: A Rapidly Evolving Field.
January 2024, Journal of the American Society of Nephrology : JASN,
D Roccatello, and M Ferro, and R Coppo, and G Mazzucco, and G Quattrocchio, and G Piccoli
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression.
November 1997, Clinical nephrology,
Copied contents to your clipboard!